Pfizer Inc. raised its forecast for product sales of its Covid-19 vaccine this 12 months to about $36 billion, a roughly 7% improve from earlier projections that shows the selection many governments have for the shot over rivals.
The New York-based drugmaker talked about its product sales forecast for the vaccine it developed with affiliate BioNTech SE shows expectations to ship about 2.3 billion vaccine doses this 12 months. The companies have grown their capabilities for manufacturing doses, they often have begun working with other firms overseas to provide doses.
https://www.wsj.com/articles/pfizer-ups-covid-19-vaccine-forecast-as-sales-more-than-double-11635853492?mod=pls_whats_news_us_business_f | Pfizer Ups Covid-19 Vaccine Forecast as Product sales Additional Than Double
